-
-
-
-
Manufacturing
-
Piperacillin Sodium/Tazobactam Sodium for injection approved by US FDA
ABOUT US
Piperacillin Sodium/Tazobactam Sodium for injection approved by US FDA
Release time：
2018-08-13
Qilu Pharmaceutical announces that Piperacillin Sodium/Tazobactam Sodium for injection manufactured by its subsidiary Qilu Tianhe Pharmaceutical was approved by US FDA on August 13, 2018. The product was already approved in many countries, including the EU, Japan, Australia, Singapore, South Africa, etc.
Related News
0531-83126666 
wangzhan@qilu-pharma.com 
Tel: +86-531-83127705, 83127704, 83127706, 83127711
Address: 8888 Lvyou Road, High-tech Zone, Jinan, 250104, China
E mail：export@qilu-pharma.com, FDF@qilu-pharma.com